Cardiovascular and inflammatory response to cholecystokinin during endotoxemic shock

Shock

Volumn 39, Issue 1, 2013, Pages 104-112

  Saia, Rafael Simone ^a   Bertozi, Giuliana ^a   Mestriner, Fabíola Leslie ^a   Antunes Rodrigues, José ^a   Queiróz Cunha, Fernando ^a   Cárnio, Evelin Capellari ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

aorta; CCK; hypotension; interleukin 10; macrophage; nitric oxide; Tumor necrosis factor

Indexed keywords

CHOLECYSTOKININ; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LACTIC ACID; LIPOPOLYSACCHARIDE; NITRATE; PROGLUMIDE; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CANNULATION; CARDIOVASCULAR RESPONSE; ENDOTOXEMIA; FEMORAL ARTERY; HEART RATE; HYPOTENSION; INFLAMMATION; JUGULAR VEIN; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN ANALYSIS; RAT; SEPTIC SHOCK; WESTERN BLOTTING;

ANIMALS; AORTA; BLOOD PRESSURE; CHOLECYSTOKININ; DRUG EVALUATION, PRECLINICAL; ENDOTOXEMIA; HEART RATE; HYPOTENSION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LACTIC ACID; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES, PERITONEAL; MALE; NITRIC OXIDE SYNTHASE TYPE II; PROGLUMIDE; RATS; RATS, WISTAR; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASOPRESSINS;

EID: 84871968936     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182793e2e     Document Type: Article

References (35)

1. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, Cal RG, de Sousa EF, Abe TP, de Andrade J, et al.: Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 8(4):R251YR260, 2004.
2. Ulloa L, Tracey KJ: The Bcytokine profile[: A code for sepsis. Trends Mol Med 11(2):56-63, 2005.
3. Wacharasint P, Nakada TA, Boyd JH, Russell JA, Walley KR: Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 38(1):4-10, 2012.
4. O'Dwyer MJ, Mankan AK, Stordeur P, O'Connell B, Duggan E, White M, Kelleher DP, McManus R, Ryan T: The occurrence of severe sepsis and septic shock are related to distinct patterns of cytokine gene expression. Shock 26(6):544-550, 2006.
5. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4(2):89-95, 1995.
6. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30(SUPPL1):S58YS63, 2002.
7. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL: Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12(4):183-187, 1997.
8. Latifi SQ, O'Riordan MA, Levine AD: Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 70(8):4441-4446, 2002.
9. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D: Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96(5):2339-2347, 1995.
10. Hickey MJ, Issekutz AC, Reinhardt PH, Fedorak RN, Kubes P: Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 83(11):1124-1131, 1998.
11. Hallemeesch MM, Janssen BJ, de Jonge WJ, Soeters PB, Lamers WH, Deutz NE: NO production by cNOS and iNOS reflects blood pressure changes in LPSchallenged mice. Am J Physiol 285(4):E871YE875, 2003.
12. Chen SJ, Li SY, Shih CC, Liao MH, Wu CC: NO contributes to abnormal vascular calcium regulation and reactivity induced by peritonitis-associated septic shock in rats. Shock 33(5):473-478, 2010.
13. Chandra R, Liddle RA: Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14(1):63-67, 2007.
14. Dufresne M, Seva C, Fourmy D: Cholecystokinin and gastrin receptors. Physiol Rev 86(3):805-847, 2006.
15. Janssen PJ, Gardiner SM, Compton AM, Bennett T: Nechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats. Br J Pharmacol 102(1):123-134, 1991.
16. Lovick TA: CCK as a modulator of cardiovascular function. J Chem Neuroanat 38(3):176-184, 2009.
17. Weiland TJ, Kent S, Voudouris NJ, Shulkes A: The effect of lipopolysaccharide on cholecystokinin in murine plasma and tissue. Peptides 26(3):447-455, 2005.
18. Guarini S, Vergoni AV, Bertolini A: Nechanism of action of the anti-shock effect of CCK-8: Influence of CCK antagonists and of sympatholytic drugs. Pharmacol 37(5):286-292, 1988.
19. Zhao XY, Ling YL, Li YG, Meng AH, Xing HY: Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats. World J Gastroenterol 11(22):3405-3410, 2005.
20. Xu SJ, Gao WJ, Cong B, Yao YX, Gu ZY: Effect of lipopolysaccharide on expression and characterization of cholecystokinin receptors in rat pulmonary interstitial macrophages. Acta Pharmacol Sin 25(10):1347-1353, 2004.
21. AlvarezA, Ibiza S, Hernandez C, Alvarez-Barrientos A, Esplugues JV, Calatayud S: Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori. FASEB J 20(13): 2396-2398, 2006.
22. Marshall M, Keeble J, Moore PK: Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia. Br J Pharmacol 149(5): 516-522, 2006.
23. Carnio EC, Stabile AM, Batalhao ME, Silva JS, Antunes-Rodrigues J, Branco LG, Magder S: Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase. Pflugers Arch 450(6):390-394, 2005.
24. Nguyen NQ, Fraser RJ, Bryant LK, Chapman MJ, Wishart J, Holloway RH, Butler R, Horowitz M: The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patients. Crit Care 11(6): R132, 2007.
25. Ling YL, Meng AH, Zhao XY, Shan BE, Zhang JL, Zhang XP: Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol 7(5):667-671, 2001.
26. Ohlsson B, Borg K, Mulder H, Rehfeld JF, Axelson J, Sundler F: Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas. Scand J Gastroenterol 35(6):612-618, 2000.
27. Peng T, Lu X, Lei M, Moe GW, Feng Q: Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc Res 59(4):893-900, 2003.
28. Lubbers T, De Haan JJ, Hadfoune M, Zhang Y, Luyer MD, Grundy D, Buurman WA, Greve JW: Lipid-enriched enteral nutrition controls the inflammatory response in murine gram-negative sepsis. Crit Care Med 38(10):1996-2002, 2010.
29. Gunnett CA, Lund DD, Faraci FM, Heistad DD: Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction. Am J Physiol 289(2): H624YH630, 2005.
30. Tan BB, Prewitt RL, Britt LD: Interleukin-10 prevents loss of tone of rat skeletal muscle arterioles exposed to endotoxin. J Surg Res 100(1):110-115, 2001.
31. Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P: Complexity of inducible nitric oxide synthase: Cellular source determines benefit versus toxicity. Circulation 108(9):1107-1112, 2003.
32. Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C, Ling Y: CCK-8 inhibits LPS-induced IL-1beta production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-kappaB pathway. Shock 27(6): 678-686, 2007.
33. Pils MC, Pisano F, Fasnacht N, Heinrich JM, Groebe L, Schippers A, Rozell B, Jack RS, Muller W: Nonocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur J Immunol 40(2):443-448, 2010.
34. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182(3):1155-1159, 1992.
35. Jarvis CR, Van de Heijning BJ, Renaud LP: Cholecystokinin evokes vasopressin release from perfused hypothalamic-neurohypophyseal explants. Regul Pept 56(2-3):131-137, 1995.